Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI ACWI ETF (ACWI) vs Amylx Pharmaceuticals Inc (AMLX) Price & Performance

iShares MSCI ACWI ETFTrade
Amylx Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

iShares MSCI ACWI ETF vs Amylx Pharmaceuticals Inc — how do they compare? iShares MSCI ACWI ETF trades at $161.9, while Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B). Which is the better fit depends on your goals.

ACWIAMLX
52-Week High
$161.44$24.19
52-Week Low
$132.04$7.82
Market Cap
$2.64B
Sector
Health
Enterprise Value
$2.39B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares MSCI ACWI ETF

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted market capitalization index designed to measure the combined equity market performance of developed and emerging markets countries.

Read more on ACWI

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX